tiprankstipranks
Advertisement
Advertisement

CORT Stock Latest News

Corcept Therapeutics assumed with a Buy at Truist
The FlyCorcept Therapeutics assumed with a Buy at Truist
3d ago
CORT
Corcept Therapeutics Earnings Call Signals Accelerating Growth
PremiumCompany Announcements
Corcept Therapeutics Earnings Call Signals Accelerating Growth
4d ago
CORT
OTLK, HBAN, CORT, CAPR, GOSS Trending With Analysts
PremiumWeekend Updates
OTLK, HBAN, CORT, CAPR, GOSS Trending With Analysts
20d ago
CAPR
CORT
Buy/Sell: Wall Street’s top 10 stock calls this week
PremiumThe Fly
Buy/Sell: Wall Street’s top 10 stock calls this week
21d ago
GM
TP
Midday Fly By: Microsoft reports sharp Q4 beat, Meta misses on earnings
PremiumThe Fly
Midday Fly By: Microsoft reports sharp Q4 beat, Meta misses on earnings
22d ago
BE
MA
Corcept: Strong Lifyorli Launch But Legal and Regulatory Risks Keep Sell Rating and $50 Price Target Unchanged
PremiumRatingsCorcept: Strong Lifyorli Launch But Legal and Regulatory Risks Keep Sell Rating and $50 Price Target Unchanged
22d ago
CORT
Corcept Therapeutics price target raised to $161 from $150 at Canaccord
Premium
The Fly
Corcept Therapeutics price target raised to $161 from $150 at Canaccord
22d ago
CORT
Corcept Therapeutics price target raised to $165 from $88 at Piper Sandler
Premium
The Fly
Corcept Therapeutics price target raised to $165 from $88 at Piper Sandler
22d ago
CORT
Corcept Therapeutics price target raised to $165 from $95 at H.C. Wainwright
PremiumThe Fly
Corcept Therapeutics price target raised to $165 from $95 at H.C. Wainwright
22d ago
CORT
Corcept Therapeutics Raises 2026 Revenue Outlook on Momentum
PremiumCompany Announcements
Corcept Therapeutics Raises 2026 Revenue Outlook on Momentum
23d ago
8K
CORT
Corcept Therapeutics reports Q2 EPS 36c, consensus 5c
PremiumThe Fly
Corcept Therapeutics reports Q2 EPS 36c, consensus 5c
23d ago
CORT
Corcept Therapeutics price target raised to $150 from $135 at Canaccord
PremiumThe Fly
Corcept Therapeutics price target raised to $150 from $135 at Canaccord
23d ago
CORT
Corcept Therapeutics downgraded to Underperform from Peer Perform at Wolfe Research
PremiumThe FlyCorcept Therapeutics downgraded to Underperform from Peer Perform at Wolfe Research
25d ago
CORT
Is CORT a Buy, Before Earnings?
Premium
Pre-Earnings
Is CORT a Buy, Before Earnings?
25d ago
CORT
Corcept Resubmits FDA Application for Relacorilant in Cushing’s
Premium
Company Announcements
Corcept Resubmits FDA Application for Relacorilant in Cushing’s
2M ago
8K
CORT
Corcept Therapeutics resubmits NDA for Relacorilant in Cushing’s Syndrome
PremiumThe Fly
Corcept Therapeutics resubmits NDA for Relacorilant in Cushing’s Syndrome
2M ago
CORT
Mega-Cap Concentration Has Hidden Active Growth’s Best Story: Inside the F/m Emerald Special Situations ETF (SPIT) and a 1st-Percentile Morningstar Track Record
PremiumMarket News
Mega-Cap Concentration Has Hidden Active Growth’s Best Story: Inside the F/m Emerald Special Situations ETF (SPIT) and a 1st-Percentile Morningstar Track Record
2M ago
EE
GH
Corcept announces presentation of new data from Catalyst, Momentum trials
PremiumThe Fly
Corcept announces presentation of new data from Catalyst, Momentum trials
2M ago
CORT
Corcept Faces Amended Qui Tam Complaint After DOJ Exit
PremiumCompany Announcements
Corcept Faces Amended Qui Tam Complaint After DOJ Exit
3M ago
8K
CORT
Corcept stockholders approve expanded incentive plan and board
PremiumCompany AnnouncementsCorcept stockholders approve expanded incentive plan and board
3M ago
8K
CORT
Corcept Therapeutics price target raised to $135 from $110 at Canaccord
Premium
The Fly
Corcept Therapeutics price target raised to $135 from $110 at Canaccord
3M ago
CORT
Corcept Therapeutics price target raised to $95 from $75 at H.C. Wainwright
Premium
The Fly
Corcept Therapeutics price target raised to $95 from $75 at H.C. Wainwright
3M ago
CORT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >